69 results
Page 2 of 4
8-K
EX-99.1
rxfsgi61h aj88nuzha
5 May 22
Maravai Lifesciences Reports First Quarter 2022 Financial Results
12:00am
8-K
EX-99.1
9dd7 xyg1shd5
28 Jan 22
Maravai LifeSciences Acquires MyChem, a Leader in Proprietary Ultra-Pure Nucleotides
8:03am
8-K
EX-10.1
f0jt103
20 Jan 22
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
n2j5hgzvuskd24
3 Sep 21
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-2.1
j6y0vlqe3kj euj3rk
10 Aug 21
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
4:18pm
10-Q
k9l4se3
12 May 21
Quarterly report
4:26pm
10-K
9oodpt8927a9x
22 Mar 21
Annual report
4:22pm
8-K
EX-1.1
lpy npx91o
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.8
j8b1fegs9nt
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.10
mb04iwp90s870bll95a6
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.9
pzr8cxm6zb6 yj662
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
424B4
bepnvbrev mbo
23 Nov 20
Prospectus supplement with pricing info
4:36pm
S-1/A
EX-1.1
b3rhop3vw1j4bnh9df
9 Nov 20
IPO registration (amended)
2:05pm
S-1/A
EX-10.26
0rbupp6w
9 Nov 20
IPO registration (amended)
2:05pm